Enanta Pharmaceuticals Inc Net Asset Quality Index
Enanta Pharmaceuticals Inc net asset quality index. Enanta Pharmaceuticals Inc (ENTA) has a Net Asset Quality Index of 34.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $296.87 Million minus total liabilities of $195.80 Million yields net assets of $101.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Enanta Pharmaceuticals Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Enanta Pharmaceuticals Inc (2011–2025)
Net asset quality index of Enanta Pharmaceuticals Inc from 2011 to 2025. This chart shows how Enanta Pharmaceuticals Inc's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 34.0%, representing net assets of $101.07 Million against total assets of $296.87 Million USD. Check how strategically is Enanta Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Enanta Pharmaceuticals Inc Net Asset Quality Index by Year (2011–2025)
Enanta Pharmaceuticals Inc net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Enanta Pharmaceuticals Inc from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ENTA market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 23.1% | $64.72 Million | $280.73 Million | $216.01 Million | ▼ -11.1 pp |
| 2024 | 34.2% | $128.81 Million | $376.65 Million | $247.84 Million | ▼ -12.7 pp |
| 2023 | 46.9% | $216.74 Million | $462.27 Million | $245.54 Million | ▼ -37.5 pp |
| 2022 | 84.4% | $321.33 Million | $380.59 Million | $59.26 Million | ▼ -6.2 pp |
| 2021 | 90.6% | $399.43 Million | $440.86 Million | $41.43 Million | ▼ -2.2 pp |
| 2020 | 92.8% | $455.58 Million | $490.79 Million | $35.21 Million | ▼ -1.6 pp |
| 2019 | 94.4% | $462.49 Million | $489.83 Million | $27.34 Million | ▼ -0.6 pp |
| 2018 | 95.0% | $393.68 Million | $414.23 Million | $20.55 Million | ▲ +2.7 pp |
| 2017 | 92.4% | $301.68 Million | $326.64 Million | $24.96 Million | ▼ -3.6 pp |
| 2016 | 96.0% | $269.94 Million | $281.28 Million | $11.34 Million | ▼ 0.0 pp |
| 2015 | 96.0% | $236.16 Million | $246.01 Million | $9.86 Million | ▲ +0.3 pp |
| 2014 | 95.6% | $148.65 Million | $155.41 Million | $6.76 Million | ▲ +1.2 pp |
| 2013 | 94.4% | $110.47 Million | $116.97 Million | $6.50 Million | ▲ +10.2 pp |
| 2012 | 84.2% | $43.93 Million | $52.16 Million | $8.23 Million | ▲ +589.9 pp |
| 2011 | -505.7% | $-131.96 Million | $26.10 Million | $158.06 Million | — |